Previous 10 |
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Oct. 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the quarter ended September 30, 2018. "We are pleased to see continued growth in the number of U.S. pati...
ACOR , ADP , AEE , AIT , ANTM , APO , APTV , ARCC , AUO , BAX , BCOR , BDC , BG , CAMT , CBZ , CDW , CG , CIM , CLH , CLX , CRTO , CVE , DBD , DIN , EGL , EL , EPD , ETR , GM , GNC , GRMN , HCP , HES , HFC , HSC , IART , ICE , ICPT , IGT , K , LFUS ,...
MannKind (MNKD) investors are in for an interesting week. Afrezza scripts came in essentially flat for the week ending October 19th, and we should see a cash infusion of $45 million relating to the United Therapeutics (UTHR) deal. On top of that, United Therapeutics is scheduled to have a qua...
With the news that MannKind ( MNKD ) inked a deal with United Therapeutics ( UTHR ), MannKind's stock rose and long term investors who have suffered through the last few years saw a new breath of hope around this equity. The purpose of this article is not to take the proverbial wind out of t...
With the Memorial Sloan Kettering Cancer Center as a shareholder and two Phase-2 product candidates intended for the treatment of Cancer, Y-mAbs (YMAB) seems a name that institutions need to assess. In addition, the company has tons of cash, no financial debt and no convertible securities, whi...
Quick Take Y-mAbs Therapeutics ( YMAB ) intends to raise $80 million in an IPO of its common stock, according to an amended registration statement . The company is advancing a pipeline of antibody-based immunotherapy treatments for various cancers. YMAB has a deep collaboration and pa...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...